Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NYXH
#5460
Nyxoah SA Ordinary Shares
4.0
8
-8.11%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-8.11%
Monatliche Änderung
-13.74%
6 month change
-33.66%
Jahresänderung
-58.91%
Vorheriger Schlusskurs
4.4
4
Open
3.9
7
Bid
Ask
Low
3.9
4
High
4.1
1
Volumen
67
Märkte
Aktien
Gesundheitswesen
NYXH
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.43 M
117.72 M
Valuation ratios
Enterprise value
299.42 M
1.16 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Nachrichten
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel maintient sa recommandation d’achat sur l’action Nyxoah avec un objectif de 12$
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Inspire Medical Systems stock soars after Medicare reimbursement boost
Stifel relève Inspire Medical Systems à l’achat suite à une hausse des remboursements
Piper Sandler abaisse l’objectif de cours de l’action Nyxoah à 9€
Piper Sandler lowers Nyxoah stock price target to $9 from $12
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah obtient jusqu’à 77 millions $ de financement pour la commercialisation de Genio
Nyxoah secures up to $77 million in financing for Genio commercialization
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday